Findings from the World Health Organization’s SOLIDARITY trial found that remdesivir, which was recently administered to President Trump, does not reduce COVID-19 mortality or speed recovery. In fact, the researchers found that no anti-viral treatments, including hydroxychloroquine, reduced mortality, use of ventilation, or duration of hospitalization.
These findings stand in direct contrast to other studies which found that treatment with remdesivir did result in clinical improvements. It’s important to recognize that remdesivir is the only antiviral treatment that is FDA approved for treatment of COVID-19.